Intuitive Surgical Inc. (ISRG) Receives “Outperform” Rating from Leerink Swann
Intuitive Surgical Inc. (NASDAQ:ISRG)‘s stock had its “outperform” rating reiterated by equities research analysts at Leerink Swann in a research report issued to clients and investors on Monday. They presently have a $780.00 price target on the stock. Leerink Swann’s price objective suggests a potential upside of 13.64% from the stock’s previous close.
Several other analysts also recently weighed in on ISRG. Barclays PLC reiterated a “buy” rating on shares of Intuitive Surgical in a research note on Saturday, June 18th. Citigroup Inc. reiterated a “buy” rating on shares of Intuitive Surgical in a research note on Thursday, June 2nd. JPMorgan Chase & Co. reissued a “buy” rating on shares of Intuitive Surgical in a report on Thursday, June 2nd. Piper Jaffray Cos. reissued a “neutral” rating and issued a $700.00 price objective (up previously from $610.00) on shares of Intuitive Surgical in a report on Wednesday, July 20th. Finally, BTIG Research reissued a “neutral” rating on shares of Intuitive Surgical in a report on Wednesday, July 20th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have assigned a buy rating to the company’s stock. Intuitive Surgical has an average rating of “Buy” and a consensus price target of $701.42.
Intuitive Surgical (NASDAQ:ISRG) traded up 1.10% during trading on Monday, reaching $693.93. The company’s stock had a trading volume of 69,712 shares. The firm has a market capitalization of $26.71 billion, a P/E ratio of 39.38 and a beta of 0.73. The stock has a 50-day moving average of $688.86 and a 200 day moving average of $643.79. Intuitive Surgical has a one year low of $447.00 and a one year high of $720.01.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/19/intuitive-surgical-inc-isrg-receives-outperform-rating-from-leerink-swann.html
Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Tuesday, July 19th. The company reported $5.62 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $4.97 by $0.65. The business had revenue of $670 million for the quarter, compared to the consensus estimate of $640.69 million. Intuitive Surgical had a return on equity of 15.25% and a net margin of 26.80%. During the same quarter in the previous year, the business earned $4.57 EPS. On average, equities research analysts predict that Intuitive Surgical will post $21.30 EPS for the current fiscal year.
In other news, CFO Marshall Mohr sold 5,000 shares of the company’s stock in a transaction that occurred on Wednesday, July 27th. The stock was sold at an average price of $684.09, for a total value of $3,420,450.00. Following the completion of the sale, the chief financial officer now directly owns 6,725 shares in the company, valued at $4,600,505.25. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Mark J. Meltzer sold 3,000 shares of the company’s stock in a transaction that occurred on Monday, August 22nd. The shares were sold at an average price of $688.33, for a total value of $2,064,990.00. Following the completion of the sale, the senior vice president now owns 2,331 shares of the company’s stock, valued at $1,604,497.23. The disclosure for this sale can be found here. 3.10% of the stock is owned by insiders.
A number of hedge funds and other institutional investors have recently modified their holdings of ISRG. Norges Bank acquired a new position in shares of Intuitive Surgical during the fourth quarter valued at $156,928,000. Capstone Asset Management Co. raised its position in shares of Intuitive Surgical by 7.1% in the first quarter. Capstone Asset Management Co. now owns 3,411 shares of the company’s stock valued at $2,050,000 after buying an additional 227 shares during the last quarter. Fox Run Management L.L.C. acquired a new position in shares of Intuitive Surgical during the first quarter valued at $541,000. Lodestar Investment Counsel LLC IL raised its position in shares of Intuitive Surgical by 43.8% in the first quarter. Lodestar Investment Counsel LLC IL now owns 1,222 shares of the company’s stock valued at $734,000 after buying an additional 372 shares during the last quarter. Finally, Forte Capital LLC ADV raised its position in shares of Intuitive Surgical by 0.3% in the first quarter. Forte Capital LLC ADV now owns 1,489 shares of the company’s stock valued at $895,000 after buying an additional 5 shares during the last quarter. Institutional investors own 92.28% of the company’s stock.
About Intuitive Surgical
Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.
Receive News & Ratings for Intuitive Surgical Inc. Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Intuitive Surgical Inc. and related companies with MarketBeat.com’s FREE daily email newsletter.